These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 31700067)

  • 21. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.
    Li S; Huang Y; Huang Y; Fu Y; Tang D; Kang R; Zhou R; Fan XG
    J Exp Clin Cancer Res; 2017 Apr; 36(1):51. PubMed ID: 28403886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PLAG1 interacts with GPX4 to conquer vulnerability to sorafenib induced ferroptosis through a PVT1/miR-195-5p axis-dependent manner in hepatocellular carcinoma.
    Li J; Li Y; Wang D; Liao R; Wu Z
    J Exp Clin Cancer Res; 2024 May; 43(1):143. PubMed ID: 38745179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
    Song W; Zhang J; Xia Q; Sun M
    Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
    [No Abstract]   [Full Text] [Related]  

  • 24. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
    Front Immunol; 2021; 12():719175. PubMed ID: 34603293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis.
    Zhang YT; Li BP; Zhang B; Ma P; Wu QL; Ming L; Xie LM
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6333-6341. PubMed ID: 30338801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ferroptosis and hepatocellular carcinoma: the emerging role of lncRNAs.
    Chen H; Han Z; Su J; Song X; Ma Q; Lin Y; Ran Z; Li X; Mou R; Wang Y; Li D
    Front Immunol; 2024; 15():1424954. PubMed ID: 38846953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma.
    Tang SJ; Yang JB
    Mol Cell Biochem; 2020 Oct; 473(1-2):143-153. PubMed ID: 32607966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression.
    Zeng Z; Shi Z; Liu Y; Zhao J; Lu Q; Guo J; Liu X; Huang D; Xu Q
    Biochem Biophys Res Commun; 2021 Aug; 566():80-86. PubMed ID: 34118595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA DCST1-AS1 accelerates the proliferation, metastasis and autophagy of hepatocellular carcinoma cell by AKT/mTOR signaling pathways.
    Li J; Zhai DS; Huang Q; Chen HL; Zhang Z; Tan QF
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6091-6104. PubMed ID: 31364110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
    Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling.
    Zhang JY; Weng MZ; Song FB; Xu YG; Liu Q; Wu JY; Qin J; Jin T; Xu JM
    Int J Oncol; 2016 Apr; 48(4):1590-8. PubMed ID: 26892468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The long noncoding RNA
    Pan W; Zhang N; Liu W; Liu J; Zhou L; Liu Y; Yang M
    J Biol Chem; 2018 Nov; 293(44):17154-17165. PubMed ID: 30228180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and Clinical Significance of the Novel Long Noncoding RNA ZNF674-AS1 in Human Hepatocellular Carcinoma.
    Zhang L; He T; Yan Y; Zhang Y; Zhou X; Huang P; Kong Y; Xie M; Zhang L; Sun Q; Zhou D; Xie H; Zhou L; Zheng S; Wang W
    Biomed Res Int; 2016; 2016():3608914. PubMed ID: 27896271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The multifaceted perspectives on the regulation of lncRNAs in hepatocellular carcinoma ferroptosis: from bench-to-bedside.
    Jin X; Huang CX; Tian Y
    Clin Exp Med; 2024 Jul; 24(1):146. PubMed ID: 38960924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1.
    Ding CH; Yin C; Chen SJ; Wen LZ; Ding K; Lei SJ; Liu JP; Wang J; Chen KX; Jiang HL; Zhang X; Luo C; Xie WF
    Mol Cancer; 2018 Feb; 17(1):63. PubMed ID: 29466992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prognostic signature based on the expression profile of the ferroptosis-related long non-coding RNAs in hepatocellular carcinoma.
    Lin X; Yang S
    Adv Clin Exp Med; 2022 Oct; 31(10):1099-1109. PubMed ID: 35581934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. lncRNA RMRP knockdown suppress hepatocellular carcinoma biological activities via regulation miRNA-206/TACR1.
    Hongfeng Z; Andong J; Liwen S; Mingping B; Xiaowei Y; Mingyong L; Aimin Y
    J Cell Biochem; 2020 Feb; 121(2):1690-1702. PubMed ID: 31579977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
    Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA RP11-909N17.2 promotes proliferation, invasion, and migration of hepatocellular carcinoma by regulating microRNA-767-3p.
    Liu Q; Dai SJ; Dong L; Li H
    Biochem Cell Biol; 2020 Dec; 98(6):709-718. PubMed ID: 33210543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insight into the molecular mechanism of LINC00152/miR-215/CDK13 axis in hepatocellular carcinoma progression.
    Wang J; Zhang Y; Lu L; Lu Y; Tang Q; Pu J
    J Cell Biochem; 2019 Nov; 120(11):18816-18825. PubMed ID: 31297882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.